Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ASCLF - Gannex's NASH drug fast track'd in the U.S.


ASCLF - Gannex's NASH drug fast track'd in the U.S.

The FDA designates Fast Track designation to Gannex's, a unit of Ascletis Pharma ([[ASCLF]]) ASC42 for the treatment non-alcoholic steatohepatitis.ASC42 is an in-house developed?novel non-steroidal, selective, potent Farnesoid X Receptor agonist.

For further details see:

Gannex's NASH drug fast track'd in the U.S.
Stock Information

Company Name: Ascletis Pharma Inc.
Stock Symbol: ASCLF
Market: OTC

Menu

ASCLF ASCLF Quote ASCLF Short ASCLF News ASCLF Articles ASCLF Message Board
Get ASCLF Alerts

News, Short Squeeze, Breakout and More Instantly...